Insider Selling: Dolby Laboratories (NYSE:DLB) CMO Sells 11,876 Shares of Stock

Key Points

  • Dolby Laboratories CMO Todd Pendleton sold 11,876 shares on May 22 at an average price of $54.55, worth about $647,836. The sale cut his direct ownership by 22.26% to 41,480 shares.
  • DLB was trading lower and remains below key moving averages, opening at $55.67 and recently down 1.6%. The stock is also below its 50-day and 200-day simple moving averages, and sits near its 52-week low of $52.45.
  • Dolby’s latest results topped expectations, with quarterly EPS of $1.37 versus $1.31 expected and revenue of $395.63 million versus $385.80 million estimated. The company also maintained FY2026 guidance and continues to pay a quarterly dividend of $0.36 per share.

Dolby Laboratories (NYSE:DLB - Get Free Report) CMO Todd Pendleton sold 11,876 shares of the business's stock in a transaction on Friday, May 22nd. The stock was sold at an average price of $54.55, for a total transaction of $647,835.80. Following the transaction, the chief marketing officer directly owned 41,480 shares in the company, valued at approximately $2,262,734. The trade was a 22.26% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.

Dolby Laboratories Trading Down 1.6%

NYSE DLB opened at $55.67 on Thursday. The stock has a market cap of $5.27 billion, a P/E ratio of 22.00 and a beta of 0.86. The company's fifty day simple moving average is $59.68 and its 200-day simple moving average is $63.14. Dolby Laboratories has a 52 week low of $52.45 and a 52 week high of $77.00.

Dolby Laboratories (NYSE:DLB - Get Free Report) last posted its quarterly earnings results on Thursday, April 30th. The electronics maker reported $1.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.31 by $0.06. The firm had revenue of $395.63 million for the quarter, compared to analysts' expectations of $385.80 million. Dolby Laboratories had a net margin of 17.85% and a return on equity of 11.47%. The firm's quarterly revenue was up 7.0% on a year-over-year basis. During the same period in the prior year, the company posted $1.34 earnings per share. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. On average, research analysts expect that Dolby Laboratories will post 3.2 EPS for the current fiscal year.

Dolby Laboratories Announces Dividend




The firm also recently announced a quarterly dividend, which was paid on Wednesday, May 20th. Shareholders of record on Tuesday, May 12th were paid a dividend of $0.36 per share. The ex-dividend date was Tuesday, May 12th. This represents a $1.44 annualized dividend and a yield of 2.6%. Dolby Laboratories's payout ratio is presently 56.92%.

Wall Street Analyst Weigh In

DLB has been the subject of several recent research reports. Rosenblatt Securities reiterated a "buy" rating and set a $85.00 target price on shares of Dolby Laboratories in a research note on Friday, January 30th. Weiss Ratings restated a "hold (c-)" rating on shares of Dolby Laboratories in a research report on Friday, March 27th. Wall Street Zen lowered shares of Dolby Laboratories from a "buy" rating to a "hold" rating in a research report on Saturday, January 31st. Finally, Barrington Research restated an "outperform" rating and set a $90.00 price target on shares of Dolby Laboratories in a research report on Monday, April 27th. Three analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $90.75.

View Our Latest Stock Report on Dolby Laboratories

Institutional Investors Weigh In On Dolby Laboratories

Several institutional investors have recently bought and sold shares of the stock. Boothbay Fund Management LLC lifted its holdings in Dolby Laboratories by 4.1% in the second quarter. Boothbay Fund Management LLC now owns 4,020 shares of the electronics maker's stock worth $299,000 after purchasing an additional 157 shares during the period. Covestor Ltd lifted its holdings in Dolby Laboratories by 6.0% in the fourth quarter. Covestor Ltd now owns 3,088 shares of the electronics maker's stock worth $198,000 after purchasing an additional 175 shares during the period. Fifth Third Bancorp lifted its holdings in Dolby Laboratories by 34.7% in the fourth quarter. Fifth Third Bancorp now owns 746 shares of the electronics maker's stock worth $48,000 after purchasing an additional 192 shares during the period. State of Michigan Retirement System lifted its holdings in Dolby Laboratories by 1.4% in the first quarter. State of Michigan Retirement System now owns 14,700 shares of the electronics maker's stock worth $883,000 after purchasing an additional 200 shares during the period. Finally, Gabelli Funds LLC lifted its holdings in Dolby Laboratories by 0.4% in the third quarter. Gabelli Funds LLC now owns 49,143 shares of the electronics maker's stock worth $3,556,000 after purchasing an additional 202 shares during the period. Institutional investors and hedge funds own 58.56% of the company's stock.

Key Dolby Laboratories News

Here are the key news stories impacting Dolby Laboratories this week:

  • Positive Sentiment: Zacks Research raised several forward earnings forecasts for Dolby Laboratories, including FY2026, FY2027, FY2028, and multiple quarterly periods, which can support the case for stronger future profitability. Analyst estimate updates
  • Positive Sentiment: The firm also lifted its Q1 2027, Q2 2027, Q4 2027, Q1 2028, and Q2 2028 EPS estimates, reinforcing expectations for earnings growth over the next few years. Analyst estimate updates
  • Neutral Sentiment: Zacks Research lowered its Q3 2026 EPS estimate, showing that not all near-term expectations are improving and leaving the outlook mixed. Analyst estimate updates
  • Negative Sentiment: Dolby CMO Todd Pendleton sold 11,876 shares at an average price of $54.55, a transaction that reduced his holdings by 22.26%, which may weigh on investor sentiment. SEC filing

About Dolby Laboratories

(Get Free Report)

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company's core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby's licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.

Further Reading

Insider Buying and Selling by Quarter for Dolby Laboratories (NYSE:DLB)

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at Dolby Laboratories?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Dolby Laboratories and related companies.
From Our Partners
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.
From Our Partners

Most Read This Month

Recent Articles